We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Molecular Analysis Tool to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 05 Nov 2025

Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional variations. More...

Traditional approaches like ELISA or mass spectrometry require labeling or complex processing and can miss minute molecular differences. Now, researchers have developed a label-free analytical method called voltage-matrix nanopore profiling, which can classify biomolecules based on their intrinsic electrical signatures.

The breakthrough by researchers from The University of Tokyo (Tokyo, Japan) combines multivoltage solid-state nanopore recordings with machine learning to create a multidimensional map of molecular signals. Their research, published in Chemical Science, demonstrate how this technique can identify and classify proteins in complex mixtures without modification, paving the way for next-generation molecular diagnostics.

Solid-state nanopores act as nanoscale tunnels through which individual molecules pass, driven by ionic current. By systematically varying the voltage, the team recorded how protein molecules interacted with the nanopores under different electrical conditions. These measurements formed a voltage matrix, which captured both stable and voltage-sensitive features of each molecule. Machine learning algorithms then analyzed these features to accurately classify and distinguish proteins, even when they were mixed together.

To validate their approach, the researchers analyzed mixtures containing two cancer-related biomarkers: carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3). Using six voltage conditions, they constructed distinct signal patterns that reliably differentiated each protein. The technique also detected molecular changes when CEA bound with an aptamer—a short, synthetic DNA sequence—demonstrating its sensitivity to subtle structural alterations.

In another test using mouse serum samples, the voltage-matrix framework successfully distinguished between centrifuged and non-centrifuged sera, confirming its potential for real-world diagnostic use. The method revealed compositional differences invisible to conventional single-voltage nanopore measurements, underscoring its ability to uncover molecular diversity in complex biological fluids.

By integrating physics, nanotechnology, and artificial intelligence, this new analytical framework offers a powerful tool for understanding molecular individuality—the unique electrical signature of each molecule. It holds promise for biomedical applications ranging from disease diagnosis to environmental monitoring, providing a foundation for high-resolution, real-time molecular profiling.

“By systematically varying voltage conditions and applying machine learning, we can create a voltage matrix that reveals both robust, voltage-independent molecular features and voltage-sensitive structural changes,” said Professor Sotaro Uemura. “Our study is not simply about improving detection sensitivity — it establishes a new way to represent and classify molecular signals across voltages, allowing us to visualize molecular individuality and estimate compositions within mixtures.”

Related Links:
The University of Tokyo


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Automatic CLIA Analyzer
Shine i6000
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.